Phase <scp>III</scp> randomized clinical trial of <scp>BV</scp> ‐4051, an Ayurvedic polyherbal formulation in moderate <scp>SARS‐CoV</scp> ‐2 infections and its impact on inflammatory biomarkers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase III randomized clinical trial of BV ‐4051, an Ayurvedic polyherbal formulation in moderate SARS‐CoV ‐2 infections and its impact on inflammatory biomarkers

Published:2022-11-23 Issue:4 Volume:37 Page:1232-1241
ISSN:0951-418X
Container-title:Phytotherapy Research
language:en
Short-container-title:Phytotherapy Research

Author:

Chitre Deepa¹^ORCID,Nadkarni Satej¹^ORCID,Jagtap Namdev²^ORCID,Tulle Rahul³^ORCID,Gitte Amol⁴^ORCID,Rahate Prashant⁵^ORCID,Chaskar Sunetra⁶^ORCID,Dey Debendranath¹^ORCID

Affiliation:

1. Bioved Pharmaceuticals, Inc. San Jose California USA

2. Vishwaraj Hospital Loni Kalbhor, Pune India

3. Vedant Hospital Thane, Mumbai India

4. Siddhivinayak Hospital Thane, Mumbai India

5. Seven Star Hospital Nagpur India

6. Bioved Pharmaceuticals Pvt. Ltd. Pune India

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ptr.7683

Reference48 articles.

1. Identification of SARS-CoV-2 variants of concern in vaccine-breakthrough infections

2. Blocking TNF signaling may save lives in COVID-19 infection

3. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants

4. Indian Medicinal Plants and Formulations and Their Potential Against COVID-19–Preclinical and Clinical Research

5. Anti-SARS-CoV-2 and anti-cytokine storm neutralizing antibody therapies against COVID-19: Update, challenges, and perspectives

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of ginger (Zingiber officinale) rhizome extract in outpatients with COVID-19: A randomized double-blind placebo-control clinical trial;Medicine;2024-05-31

2. Plant‐derived compounds as potential leads for new drug development targeting COVID‐19;Phytotherapy Research;2024-01-28

3. Ayurveda: Bridging innovation for human and animal health;Journal of Research in Ayurvedic Sciences;2024-01

4. Efficacy of adaptogens in preventing and correcting stress-induced conditions;Human and nation's health;2023-12-29

5. Functional foods as immunomodulators: Tackling the SARS-CoV-2 related cytokine storm–A review;Food Chemistry Advances;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3